[1]Gh. Rasool Bhat, Rosalie G.Hyolea, JiongLi. Head and neck cancer: Current challenges and future perspectives. [J]. Advances in Cancer Research. 2021 Aug;152:67–102. [2]Daniel E. Johnson, Barbara Burtness, C. René Leemans, et al. Head and neck squamous cell carcinoma. [J]. Nat Rev Dis Primers. 2020 Nov 26; 6(1): 92.[3]杨聪翀,朱丽芳,宁天云,等. MT1-MMP miRNA 干扰载体的构建及沉默效果评价. [J]. 口腔生物医学,2012,3(3):117–123. [4]Zhang X-S, Wang K-Y, Gao J-Q, et al. Study on the expression of p53 and MMP-2 in patients with lung cancer after interventional therapy. [J]. Oncol Lett. Spandidos Publications; 2018 Oct;16(4):4291–6. [5]Ren L, Wang Y, Zhu L, et al. Optimization of a MT1-MMP-targeting Peptide and Its Application in Near-infrared Fluorescence Tumor Imaging. [J]. Nature Publishing Group. Nature Publishing Group; 2018 Jul 9;8(1):10334. [6]Ishida T, Hijioka H, Kume K, et al. Notch signaling induces EMT in OSCC cell lines in a hypoxic environment. [J]. Oncol Lett. Spandidos Publications; 2013 Nov;6(5):1201–6. [7]Yu C-C, Chen P-N, Peng C-Y, et al. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis. [J]. Oncotarget. 2016 Apr 12;7(15):20180–92. [8]Joseph JP, Harishankar MK, Pillai AA, et al. Hypoxia induced EMT: A review on the mechanism of tumor progression and metastasis in OSCC. [J]. Oral Oncology. 2018 May;80:23–32. [9]David CJ, Huang Y-H, Chen M, et al. TGF-β Tumor Suppression through a Lethal EMT. [J]. Cell. 2016 Feb;164(5):1015–30. [10]Pastushenko I, Blanpain C. EMT Transition States during Tumor Progression and Metastasis. [J]. Trends in Cell Biology. 2018 Dec. [11]张杨安,关为群,李群,等. 口腔鳞状细胞癌组织中Periostin的表达及其在上皮间质转化中的作用. [J]. 口腔医学研究,2017,33(3):262–265. [12]Park Y-J, Kim EK, Bae JY, et al. Human telomerase reverse transcriptase (hTERT) promotes cancer invasion by modulating cathepsin D via early growth response (EGR)-1. [J]. Cancer Lett. 2016 Jan;370(2):222–31. [13]da Silva SD, Alaoui-Jamali MA, Soares FA, et al. TWIST1 is a molecular marker for a poor prognosis in oral cancer and represents a potential therapeutic target. Cancer. [J]. John Wiley & Sons, Ltd; 2013 Oct 21;120(3):352–62. [14] Lagoutte E, Villeneuve C, Lafanechère L, et al. LIMK Regulates Tumor-Cell Invasion and Matrix Degradation Through Tyrosine Phosphorylation of MT1-MMP. [J]. Nature Publishing Group. Nature Publishing Group; 2016 Apr 27;6(1):362. [15]Chanda A, Sarkar A, Bonni S. The SUMO System and TGFβ Signaling Interplay in Regulation of Epithelial-Mesenchymal Transition: Implications for Cancer Progression. Cancers (Basel). [J]. Multidisciplinary Digital Publishing Institute; 2018 Aug 8;10(8):264. [16]Nguyen H-L, Kadam P, Helkin A, et al. MT1-MMP Activation of TGF-β Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer. [J]. Curr Cancer Drug Targets. 2016;16(7):618–30. |